⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 28, 2026PharmaceuticsOpen Access

Population Pharmacokinetic Models at the Forefront of Precision Dosing

Katarina Vučićević

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research focuses on how population pharmacokinetics underpins personalized medicine through improved dosing strategies.
Analyzed recent advancements in population pharmacokinetics methodology.
Examined its applications in individualized therapy and regulatory practices.
Population pharmacokinetics significantly enhances dose optimization for therapies.
Improved regulatory decision making indicates better safety and efficacy profiles for treatments.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Population pharmacokinetic models optimize dosing, improving individualized therapy and regulatory decisions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Katarina Vučićević (2026) studied this question.

synapsesocial.com/papers/69f837f53ed186a73998249b https://doi.org/10.3390/pharmaceutics18050535

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1An overview of PBPK and PopPK Models: Applications to Radiopharmaceutical Therapies for Analysis and Personalization2025
2Model-Informed Precision Dosing in Pediatrics: Current Practices, Opportunities, and ChallengesReview · 2026 · 1 citations
3Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current StrategiesNarrative Review · 2026 · 4 citations
4Recent Advances Addressing the Challenges of Precision Dosing2024 · 13 citations
5Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin2024 · 1 citations

More related papers

Physiologically-based pharmacokinetic modeling: past, present and future (review)2025
Population Physiologically‐Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare Disease2026
Advancing Daptomycin Precision Dosing Through Evaluation of Published Population Pharmacokinetic Models and Development of a Dosing Tool2026

More from Pharmaceutics

Characterization of the Gametocytocidal and Putative Transmission-Blocking Activity of Chlorotonil A Against Plasmodium falciparumFri,
From Passive Carriers to Niche Engineers: The Evolving Paradigm of Engineered Bacteria in Cancer TherapyFri,